Methotrexate for treatment of atopic dermatitis in children and adolescents.

Item

http://www.wikidata.org/entity/Q38193907

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Methotrexate for treatment of atopic dermatitis in children and adolescents.

@en

type

Item

label

Methotrexate for treatment of atopic dermatitis in children and adolescents.

@en

prefLabel

Methotrexate for treatment of atopic dermatitis in children and adolescents.

@en

P1476

Methotrexate for treatment of atopic dermatitis in children and adolescents.

@en

P2093

Anthony Yung

http://www.w3.org/2001/XMLSchema#string

Maneka Deo

http://www.w3.org/2001/XMLSchema#string

Marius Rademaker

http://www.w3.org/2001/XMLSchema#string

Sarah Hill

http://www.w3.org/2001/XMLSchema#string

P2860

Methotrexate markedly reduces the expression of vascular E-selectin, cutaneous lymphocyte-associated antigen and the numbers of mononuclear leucocytes in psoriatic skin.

Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three.

Cost of illness of atopic dermatitis in children: a societal perspective.

Narrowband UVB phototherapy in children: A New Zealand experience.

Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.

Methotrexate versus cyclosporine in the treatment of severe atopic dermatitis in children: a multicenter experience from Egypt.

A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyltransferase levels to exclude patients at high risk of myelosuppression.

Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group.

The anti-inflammatory action of methotrexate is not mediated by lymphocyte apoptosis, but by the suppression of activation and adhesion molecules.

Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.

P304

1037-1041

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/IJD.12314

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260607476

http://www.w3.org/2001/XMLSchema#string

P698

24602088

http://www.w3.org/2001/XMLSchema#string